Literature DB >> 30675984

The HIV care continuum among resident and non-resident populations found in venues in East Africa cross-border areas.

Jessie K Edwards1, Peter Arimi2, Freddie Ssengooba3, Grace Mulholland1, Milissa Markiewicz4, Elizabeth A Bukusi5, Judy T Orikiiriza6,7, Arti Virkud1, Sharon Weir1,4.   

Abstract

INTRODUCTION: HIV care and treatment in cross-border areas in East Africa face challenges perhaps not seen to the same extent in other geographic areas, particularly for mobile and migrant populations. Here, we estimate the proportion of people with HIV found in these cross-border areas in each stage of the HIV care and treatment cascade, including the proportion who knows their status, the proportion on treatment and the proportion virally suppressed.
METHODS: Participants (n = 11,410) working or socializing in public places in selected East Africa cross border areas were recruited between June 2016 and February 2017 using the Priorities for Local AIDS Control Efforts method and administered a behavioural survey and rapid HIV test. This approach was designed to recruit a stratified random sample of people found in public spaces or venues in each cross border area. For participants testing positive for HIV, viral load was measured from dried blood spots. The proportion in each step of the cascade was estimated using inverse probability weights to account for the sampling design and informative HIV test refusals. Estimates are reported separately for residents of the cross border areas and non-residents found in those areas.
RESULTS: Overall, 43% of participants with HIV found in cross-border areas knew their status, 87% of those participants were on antiretroviral therapy (ART), and 80% of participants on ART were virally suppressed. About 20% of people with HIV found in cross border areas were sampled outside their subdistrict or subcounty of residence. While both resident and non-resident individuals who knew their status were likely to be on ART (85% and 96% respectively), people on ART recruited outside their area of residence were less likely to be suppressed (64% suppressed; 95% CI: 43, 81) compared to residents (84% suppressed; 95% CI: 75, 93).
CONCLUSIONS: People living in or travelling through cross-border areas may face barriers in learning their HIV status. Moreover, while non-residents were more likely to be on treatment than residents, they were less likely to be suppressed, suggesting gaps in continuity of care for people in East Africa travelling outside their area of residence despite timely initiation of treatment.
© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Entities:  

Keywords:  East Africa; HIV Care Continuum; Viral Load; border crossing; linkage to care; sex workers; transients and migrants; viral suppression

Mesh:

Substances:

Year:  2019        PMID: 30675984      PMCID: PMC6344908          DOI: 10.1002/jia2.25226

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


Introduction

Expanding economic integration has increased cross‐border movement and trade in East Africa 1. Communities that straddle international borders, including towns along highway border crossings and communities that serve as landing sites for fishing vessels from multiple countries, are important mixing environments for transient and resident populations. Characteristics of these “cross‐border areas”, including the presence of and interaction with highly mobile populations 2, density of venues offering alcohol 3 and opportunities for sex on site, influx of individuals with disposable income 4 and market for transactional sex 5 have been linked to high levels of HIV transmission. However, traditional HIV prevention, care and treatment programmes, often designed for long‐term residents of local catchment areas, may not adequately serve the needs of people with HIV found in cross border areas. Early treatment resulting in viral suppression is an important strategy to reduce transmission of HIV from people living with HIV to their HIV‐uninfected partners 6, 7, 8. The UNAIDS 90‐90‐90 targets are designed to minimize the proportion of the population with an unsuppressed viral load by ensuring that 90% of people living with HIV know their status, 90% of those who know their status are on antiretroviral therapy (ART), and 90% of those on ART are virally suppressed 9. Baseline results from the SEARCH Trial conducted in rural communities in East Africa indicate that, prior to the intervention, over 60% of people with HIV had been previously diagnosed, nearly 80% of those who knew their status were on ART, and over 80% of those on ART were virally suppressed 10. Furthermore, the SEARCH trial, along with HIV prevention trials in other regions (e.g. the PopART trial in Zambia and South Africa 11) have identified several promising strategies to increase access to HIV testing 12, 13, retention in care 14, ART initiation 13 and viral suppression through universal testing and treatment. However, HIV care and treatment in cross‐border areas face many challenges not encountered to the same extent in other areas, including an influx of mobile and transient populations, patients lost to follow‐up across international borders, and patients presenting for treatment away from their home countries, which may use different treatment regimens 15, 16, 17. Taken together, these challenges imply that people with HIV who live, socialize and travel in cross‐border areas may not be optimally served by existing HIV care and treatment programmes predominantly administered through a country‐focused lens. Accordingly, progress towards the 90‐90‐90 goals across the East African region may be negated by programming gaps in cross‐border areas. Here, we describe the characteristics of people with HIV and progress towards the 90‐90‐90 goals in select East Africa cross‐border areas. The East Africa Cross Border Integrated Health Study (CBIHS) offers a rare opportunity to assess outcomes along the HIV care continuum for people living, working and socializing in cross‐border areas, including highly mobile cross‐border priority populations who are typically excluded from traditional epidemiologic studies implemented using household‐based surveys. Because such groups likely access services differently and face distinct sets of health risk factors 18, 19 from “resident” populations (i.e. those with a primary residence at the cross‐border area), we estimate the HIV care continuum and progress towards the 90‐90‐90 targets separately for resident and non‐resident groups.

Methods

Study procedures

The CBIHS is a population‐based cross‐sectional study of a wide array of health outcomes in 14 survey sites in cross‐border areas in Kenya, Uganda, Tanzania and Rwanda (Figure 1) conducted between June 2016 and February 2017. Of the selected sites, eight were “land border sites,” which included the area around international border posts on highways, and six were “lake border sites,” which included fishing villages on Lake Victoria that served as points of commerce for fisher folk from multiple East African countries. Land border sites included the area on both sides of the international border while lake sites contained area in a single country. All selected survey sites had a high level of cross‐border traffic and/or trade and sizeable populations.
Figure 1

Map of land cross‐border areas (orange) and lake cross‐border areas (blue) in East Africa included in the East Africa Cross Border Integrated Health Study, 2016

As part of its mission to describe health outcomes and access to care, CBIHS conducted a bio‐behavioural survey among a sample of people patronizing or working in public venues in cross‐border areas. The Priorities for Local AIDS Control Efforts (PLACE) method 20, 21 was used to sample and recruit participants. The PLACE method consists of three steps designed to provide a stratified random sample of individuals socializing in cross border areas. Step 1: Enumeration of all venues in each cross border site: Approximately 200 community informants in each cross‐border area were interviewed and each asked to provide the names and locations of up to 10 venues where people (including residents and non‐residents) socialize and meet new sexual partners. Additional community informants were interviewed until the list of venues reached saturation or no new venues were named. Step 2: Verification of a sample of venues: The team verified characteristics of a sample of up to 100 venues in each cross‐border area to ensure that venues named in step 1 existed, were unique and were operational. In areas with fewer than 100 venues, all venues were included. In areas with more than 100 venues, a stratified random sample of venues was selected for verification. Step 3: Bio‐behavioural survey: The team conducted a bio‐behavioural survey among individuals socializing at a stratified random sample of 40 venues per area. At sampled venues, a stratified sample of workers and male and female patrons was approached, with interview targets proportional to the total number of people at the venue. The appendix contains additional details on the sampling of venues and individuals. Sampled individuals were offered counselling and rapid HIV testing according to the algorithm approved by each country. In addition, respondents were asked to participate in an interview to gather sociodemographic information, health history, family information, sexual behaviour, health‐seeking behaviour, and exposure to HIV prevention, care and treatment programmes, including ART. Participants who refused the HIV test were offered the option of participating in the interview. After the interview, participants who agreed to be tested received their result and post‐test counselling. Those with positive results were asked to provide dried blood spots for HIV‐1 RNA viral load testing, which was conducted according to national guidelines in each country. People newly testing positive for HIV were linked to care at a local health facility. Viral load measurements were communicated back to the facility with which the local staff who provided the HIV counselling and testing were associated. Respondents were given a card with an identification code and facility name so that they could obtain their viral load results. Participants who refused the HIV test were not invited to provide dried blood spots for viral load quantification. To evaluate disparities in achieving the 90‐90‐90 goals between resident and non‐resident populations, we estimated the proportion in each stage separately for each group. We defined the “non‐resident” population as individuals who reported residing in a subnational administrative area (i.e. subdistrict, subcounty, parish, ward or commune) outside the cross border area where they were recruited. In contrast, the resident population consisted of individuals who reported that they reside within the subnational unit of the cross‐border area. Study protocols were reviewed and approved by the University of North Carolina at Chapel Hill Institutional Review Board; Makerere University Higher Degrees, Research, and Ethics Committee in Uganda; the Kenya Medical Research Institute Ethics Review Committee; the National Institute for Medical Research in Tanzania; and the Rwanda National Ethics Committee. All participants in the biobehavioural survey provided written informed consent.

Statistical analysis

The purpose of this analysis was to estimate indicators related to the 90‐90‐90 targets in cross‐border areas, including: The proportion of people living with HIV who know their status (the first 90) The proportion of people who know that they are living with HIV who are on ART (the second 90) The proportion of people on ART who have a suppressed viral load, defined as a viral load under 1000 copies/mL (the third 90); and The overall proportion of people living with HIV who had a detectable viral load. The questions used to ascertain whether an individual met the inclusion criteria for each step of the care continuum are provided in Table 1.
Table 1

Details on ascertainment of each step of the HIV care cascade

StepAscertainment algorithmInstrumentResponse
1. Knows statusA person living with HIV could have been considered to know his or her status in 2 ways:
1.1 Agree to the rapid HIV test and test positive; AND Rapid HIV testPOSITIVE
1.2 Report previously taking an HIV test; ANDSURVEY: Have you ever had an HIV test? YES
1.3 Report receiving the result and testing positiveSURVEY: Think back to the last test for which you collected your test result. What was the result? ORINFECTED WITH HIV
SELF‐COMPLETED: Think about the last timeyou were tested for HIV and got your test result. What was the result?
OR
2.1 Refuse the rapid HIV test; ANDMISSING
2.2 Report previously taking an HIV test; ANDSURVEY: Have you ever had an HIV test?YES
2.3. Report receiving the result and testing positiveSURVEY: Think back to the last test for which you collected your test result. What was the result? ORINFECTED WITH HIV
SELF‐COMPLETED: Think about the last time you were tested for HIV and got your test result. What was the result?
2. On ARTA person living with HIV was considered to be on treatment if he knew his status, as defined, above, and reported taking ARTSURVEY: Are you currently taking antiretroviral drugs (ART) to treat an HIV infection?YES
3. SuppressedA person living with HIV was considered to have a suppressed viral load if he or she
1. Agreed to provide a dried blood spotConsent formYES
2. Viral load was below 1000 copies/mLDried blood spot<1000 copies/mL

ART, antiretroviral therapy.

Details on ascertainment of each step of the HIV care cascade ART, antiretroviral therapy. All participants who tested positive for HIV or who reported a previous positive HIV test were included. All analyses accounted for the survey design, including clustering by recruitment venue and stratified random sampling. Survey sampling weights were used to reweight the study sample to represent all people with HIV who socialize in public venues in the selected cross‐border areas, and we accounted for missing data due to informative refusals of the HIV test and viral load testing using inverse probability weights 22. Details on estimation of the weights can be found in the Appendix. Each parameter (i.e. each 90‐90‐90 indicator) was estimated for the entire population and separately for resident and non‐resident populations. We also examined associations between achieving each stage of the HIV care continuum and other individual‐ and venue‐level characteristics using weighted bivariate (unadjusted) prevalence ratios (PRs). Corresponding 95% confidence intervals [CIs] were based on standard errors estimated using Taylor series linearization to account for the sampling design 23. Analyses were conducted in SAS 9.4 (Cary, NC). Because we aimed to quantify differences in outcomes between participants recruited within versus outside of their area of residence and not to evaluate a specific statistical hypothesis, no statistical hypothesis testing was performed 24.

Results

Description of the study sample

Of the 1,769 venues identified by community informants in the 14 cross‐border areas, 1,161 (66%) were sampled for verification. Of these sampled venues, 883 (76%) were successfully located, operational and contained a venue informant who consented to participate. A total of 452 of these venues were sampled for the bio‐behavioural survey, from which 11,567 individuals were sampled and asked to participate in the study. Of those, 11,410 (98.6%) agreed to participate in the interview and 10,549 (91.2%) agreed to be tested for HIV. Overall, 8656 (76%) of those completing the interview reported a place of residence within the cross border area and 2754 (24%) reported a place of residence outside the cross border area. Of those completing the interview, 576 individuals (5.0%) tested HIV positive or declined the HIV test and reported that they were HIV positive (460 residents and 116 non‐residents). Of the 576 people living with HIV, 58% were female (n = 347), 68% were between the ages of 20 and 40 (n = 408), 69% had completed primary school or higher education (n = 411), and 16% reported receiving cash for sex in the past 12 months (n = 98) (Table 2). Approximately 20% of people with HIV found in the cross border areas reported a place (i.e. subdistrict or subcounty) of residence outside the cross border area. These non‐resident populations with HIV were younger, better educated and more likely to be female than resident populations with HIV. The majority of both resident and non‐resident populations reported spending fewer than two weeks per year away from their primary residence, but a notable proportion of both resident and non‐resident populations spent more than one month per year away from home (24% and 30% respectively).
Table 2

Characteristics of people living with HIV found at public venues in 14 cross‐border areas selected for the East Africa Cross Border Integrated Health Study, 2016

Overall (N = 576)Resident (n = 460)Non‐resident (n = 116)
CharacteristicsSample n Population %a Population %Population %
Gender
Male22941.843.933.4
Female34758.256.166.6
Age
15 to 19213.82.78.2
20 to 2921035.234.538.1
30 to 39 19832.932.833.3
40+14728.13020.4
Employed45877.978.276.8
Paid cash for sex in past 12 months7612.012.410.1
Currently married or living with a partner29051.454.239.9
Education
Less than primary16330.931.428.8
Completed primary32757.158.053.2
Completed secondary547.45.614.3
More than secondary304.75.03.7
Type of venue where recruited
Bar/pub/restaurant27649.448.453.1
Hotel/guest house/lodge11719.619.918.5
Nightclub/disco/brothel203.23.71.5
Commercial venueb 347.35.913
Outside venuec 5710.211.74.2
Transportation hubd 50.60.41.5
Other609.710.08.1
Time spent away from primary residence in past year
Two weeks or less33960.060.060.2
More than two weeks but less than one month8614.916.110.3
More than one month but not more than three months519.87.718.1
More than three months6810.511.37.6
Refused284.74.93.9
Type of respondent
Workers at venues19732.231.435.2
Patrons at venues37967.868.664.8
Recruited in a land border site32460.654.585.3
Recruited in a lake border site25239.445.514.7
Visited more than one venue on day of recruitment25446.046.045.8
Recruited at a venue where people have sex on site31649.648.051.8
Member of cross‐border priority populatione
Female sex worker (received cash for sex in past 12 months)9815.911.832.4
Fisher folk9414.515.610.0
Long distance truck driver91.31.31.1
Female worker at venue14023.121.529.6
Young woman (ages 15 to 19)9516.014.323.0

aPopulation percentages were obtained by weighting the study sample to accommodate the complex sampling design; bCommercial venues included markets, hair salons, shops, cinemas, recreation and game centres and schools; cOutdoor venues included beaches, parks, construction sites and streets; dTransportation hubs included truck stops and lorry/railway stations; eCross border priority populations were identified by local stakeholders and are not mutually exclusive

Characteristics of people living with HIV found at public venues in 14 cross‐border areas selected for the East Africa Cross Border Integrated Health Study, 2016 aPopulation percentages were obtained by weighting the study sample to accommodate the complex sampling design; bCommercial venues included markets, hair salons, shops, cinemas, recreation and game centres and schools; cOutdoor venues included beaches, parks, construction sites and streets; dTransportation hubs included truck stops and lorry/railway stations; eCross border priority populations were identified by local stakeholders and are not mutually exclusive

Progress towards the 90‐90‐90 indicators

Among the 576 people living with HIV identified by the study, 270 already knew their status (weighted percentage: 43.0%; 95% CI: 38.2, 47.8) and 234 knew their status and were receiving ART (weighted percentage: 37.2%; 95% CI: 32.7, 41.8). Of those living with HIV, 29.5% knew their status, were receiving ART, and were virally suppressed (95% CI: 23.7, 35.2). These weighted percentages and 95% confidence intervals are compared visually to the 90‐90‐90 targets in Figure 2.
Figure 2

Marginal percentages of people living with HIV in each stage of the HIV care and treatment cascade and 95% confidence intervals in comparison to the 90‐90‐90 goals in the East Africa Cross Border Integrated Health Study, 2016

Table 3 presents the weighted percentages of participants in each step of the cascade achieving the subsequent step overall and for resident and non‐resident subgroups. For example, among the 43.0% who knew their status, 86.6% were receiving ART, and among those receiving ART, 80.4% had a suppressed viral load. Under half of both resident and non‐resident populations with HIV knew their status, falling far short of the first of the 90‐90‐90 targets. However, among resident populations, the proportion of those who knew their status being on ART and the proportion of those on ART who were suppressed approached the second and third targets of 90%. In contrast, though almost all of the non‐resident population members who knew their status were on ART, only 64% of those on ART were suppressed. Figure 3 compares the marginal proportions of resident and non‐resident populations in each stage of the continuum of care to the 90‐90‐90 targets and highlights the disparity in the overall proportion suppressed between resident and non‐resident groups (31% (95% CI: 25, 37) vs. 21% (95% CI: 10, 33) respectively).
Table 3

Estimated percentage of people living with HIV meeting each of the 90‐90‐90 targets for the overall, resident and non‐resident populations in selected cross‐border areas in East Africa, 2016

Overall (N = 576)Resident (n = 460)Non‐resident (n = 116)
Population %95% CIPopulation %95% CIPopulation %95% CI
First 90: Among those with HIV, knowledge of status43.038.2, 47.844.038.6, 49.438.926.9, 50.9
Second 90: Of those who know their status, on ART86.682.2, 91.184.579.3, 89.896.293.2, 99.1
Third 90: Of those on ART, virologically suppressed80.472.5, 88.483.974.5, 93.264.047.3, 80.8

ART, antiretroviral therapy.

Figure 3

Marginal percentages of people living with HIV in each stage of the HIV care and treatment cascade and 95% confidence intervals in comparison to the 90‐90‐90 targets for resident and non‐resident populations in the East Africa Cross Border Integrated Health Study, 2016

Estimated percentage of people living with HIV meeting each of the 90‐90‐90 targets for the overall, resident and non‐resident populations in selected cross‐border areas in East Africa, 2016 ART, antiretroviral therapy.

Relationship between the 90‐90‐90 targets and participant characteristics

Overall, the strongest risk factors for having a detectable viral load were being a non‐resident of the cross border area (compared with residents of the area), being a young woman between the ages of 18 and 24 (compared with being an older woman), and being recruited at a commercial venue (e.g. market, salon), outdoor venue (e.g. sex worker street, beach, park), or other type of venue (e.g. truck stop, railway station), compared with being recruited at a bar, pub or restaurant (Table 4). Workers at venues were less likely to have a detectable viral load than patrons at venues and people working in jobs related to the fishing industry were less likely to have a detectable viral load than other participants. Associations between characteristics and individual steps of engagement in the cascade were more nuanced. For example, workers at venues were more likely to know their status (PR: 1.36, 95% CI: 1.10, 1.67) and to be virally suppressed, given that they were on ART, (PR: 1.23; 95% CI: 1.00, 1.51) than other respondents, though being a worker at a venue was not associated with being on ART (PR: 1.02; 95% CI: 0.93, 1.12). Moreover, working in a job related to the fishing industry was associated with a higher probability of knowing one's status (PR: 1.74; 95% CI: 1.41, 2.14), but was not strongly associated with being on ART (PR: 1.08; 95% CI: 0.95, 1.22), or viral suppression, conditional on being on ART (PR: 0.90; 95% CI: 0.73, 1.11).
Table 4

Prevalence ratios describing the associations between individual‐ and venue‐level characteristics and achievement of the 90‐90‐90 goals among people in the East Africa Cross Border Integrated Health Study, 2016

First 90: Among those with HIV, knowledge of statusSecond 90: Of those who know their status, on ARTThird 90: Of those on ART, virally suppressedOverall probability of having a detectable viral load
PR95% CIPR95% CIPR95% CIPR95% CI
Population type
Resident1111
Non‐resident0.880.63, 1.241.141.06, 1.220.760.58, 1.011.150.96, 1.37
Gender
Male111
Female1.160.96, 1.400.970.88, 1.081.140.95, 1.360.910.77, 1.08
Age
15 to 29 1111
30 to 39 0.710.57, 0.871.030.49, 2.171.590.32, 7.820.840.68, 1.02
40+ 0.710.55, 0.910.360.12, 1.032.480.57, 10.770.850.68, 1.07
Received cash for sex in past 12 months
No1111
Yes1.200.92, 1.570.930.81, 1.081.010.77, 1.330.920.71, 1.20
Works in job related to the fishing industry
No1111
Yes1.741.41, 2.141.080.95, 1.220.900.73, 1.110.780.56, 1.08
Long‐distance truck drivers
Other men11
Truck drivers1.220.50, 2.970.930.59, 1.49NANA
Female workers at venues
Other women1111
Female worker1.130.85, 1.491.030.90, 1.171.170.95, 1.450.850.65, 1.10
Young women
Women 25 and older1111
Women 15 to 240.400.26, 0.620.900.69, 1.171.090.87, 1.361.371.10, 1.71
Employment
Employed1111
Unemployed0.880.64, 1.210.980.86, 1.131.000.76, 1.321.130.95, 1.34
Paid cash for sex in past 12 months
No1111
Yes0.880.63, 1.241.000.86, 1.171.221.06, 1.400.930.66, 1.30
Currently married or living with a partner
No1111
Yes0.990.80, 1.221.131.02, 1.260.930.77, 1.120.960.79, 1.16
Education
Less than primary1111
Completed primary1.010.77, 1.330.820.39, 1.711.520.81, 2.861.050.86, 1.29
Completed secondary0.960.72, 1.300.500.26, 0.972.220.77, 6.370.970.73, 1.29
More than secondary0.800.49, 1.311.000.78, 1.28NA1.170.95, 1.43
Type of venue where recruited
Bar/pub/restaurant1111
Hotel/guest house/lodge0.970.66, 1.421.450.62, 3.390.620.14, 2.830.710.39, 1.29
Nightclub/disco/brothel0.970.41, 2.312.921.52, 5.611.570.71, 3.470.840.41, 1.71
Commercial venuesa 0.830.63, 1.090.890.50, 1.580.810.42, 1.551.541.01, 2.35
Outside venuesb 0.480.29, 0.801.930.76, 4.890.300.05, 1.731.760.98, 3.16
Otherc 0.720.49, 1.070.970.86, 1.100.270.09, 0.801.280.49, 3.32
Time spent away from primary residence in past year
Less than one month1111
One month or more0.850.65, 1.111.050.92, 1.210.980.76, 1.271.080.84, 1.38
Type of respondent
Patrons at venues1111
Workers at venues1.361.10, 1.671.020.93, 1.121.231.00, 1.510.760.62, 0.94
Type of site where recruited
Land site1111
Lake site1.681.33, 2.121.070.97, 1.190.960.80, 1.160.890.74, 1.06
Visited more than one venue on day of recruitment0.950.74, 1.231.040.94, 1.140.960.79, 1.171.030.89, 1.21
Recruited at a venue where people have sex on site0.950.73, 1.220.990.89, 1.101.100.91, 1.340.980.83, 1.16

PR, Prevalence ratio; CI, confidence interval; ART, antiretroviral therapy

aCommercial venues included markets, hair salons, shops, cinemas, recreation and game centres, and schools; bOutdoor venues included beaches, parks, construction sites and streets; cOther venues included truck stops, railway/lorry stations and other types of venues

Prevalence ratios describing the associations between individual‐ and venue‐level characteristics and achievement of the 90‐90‐90 goals among people in the East Africa Cross Border Integrated Health Study, 2016 PR, Prevalence ratio; CI, confidence interval; ART, antiretroviral therapy aCommercial venues included markets, hair salons, shops, cinemas, recreation and game centres, and schools; bOutdoor venues included beaches, parks, construction sites and streets; cOther venues included truck stops, railway/lorry stations and other types of venues

Discussion

People with HIV working or socializing in East Africa cross‐border areas were unlikely to know their HIV status, although those who knew their HIV status were likely to be on treatment and suppressed: while only 43% knew their HIV‐positive status, 84% of people who knew their status were on ART and 80% of those on ART had a suppressed viral load. Both resident and non‐resident populations who knew their status were likely to be on treatment, with a notable 96% of non‐resident individuals who knew their status on treatment, suggesting that HIV care and treatment programmes are successfully starting members of this important population on treatment. However, only 64% of non‐resident individuals on treatment were suppressed, which could point to gaps in continuity of care, poor adherence or antiretroviral resistance among populations spending time outside their areas of residence in East Africa. Cross‐border areas in East Africa are approaching the UNAIDS 90‐90‐90 goals for the proportion on ART and the proportion virally suppressed, but they fall well short of the target for the proportion of people living with HIV who know their status. These results suggest that East Africa cross border areas may be falling behind other areas in the region; UNAIDS reports that only 76% of adults with HIV between the ages of 15 and 49 in Eastern and Southern Africa knew their status as of 2017, that 60% were on ART, and that 50% were virally suppressed 25. Furthermore, the estimated proportion of people living with HIV who knew their status was lower in the selected cross‐border areas (43%) than in the baseline results from the SEARCH trial conducted in rural Kenyan and Ugandan communities in 2015 (65%) 10, the Uganda Population‐based HIV Impact Assessment conducted in 2016 to 2017 (73%) 26, or the Tanzania Population‐based HIV Impact Assessment conducted in 2016 to 2017 (52%)27. Many factors may contribute to the low proportion of people with HIV who knew their status in cross‐border areas. First, cross‐border areas contain mobile groups, including truck drivers and traders, who may be missed by routine facility‐based services or community‐based testing focused on residents who spend most of their time in the area. In addition, HIV testing during regular health facility hours may be incompatible with full‐time employment, farming or family responsibilities 28. Outreach testing in public places or home‐based testing may be more effective than health facility‐based testing 12, 29, 30, 31, specifically for the mobile and migrant populations found in cross‐border areas. Furthermore, the majority of respondents (60%) who were HIV positive but did not know their status reported taking an HIV test within the previous 12 months. This high prevalence of HIV testing among people who did not know their status suggests that increasing the proportion of people living with HIV who know their status will require frequent retesting of people previously testing negative for HIV, which may be more feasible if testing is conducted outside the health facility or using home‐based testing. Despite the low proportion of people with HIV who knew their status, people who did know their status were likely to be on treatment, pointing to successful scale‐up of HIV treatment programmes in East Africa. The CBIHS was conducted in 2016, a year when treatment guidelines in East Africa were shifting from CD4 cell count‐based thresholds for treatment initiation to a test and treat strategy. As immediate treatment continues to be normalized throughout the region, the proportion of those who know their status who are on treatment is expected to increase even further. Outcomes measured in CBIHS in cross‐border areas may differ from outcomes measured in other studies due to differences in the sampling and recruitment techniques. For example, we sampled from people socializing in public places (“venues”), with the goal of recruiting a cross‐section of people who could be found in a cross‐border area at a given point in time. In contrast, other studies often employ household surveys to recruit residents of the selected communities. Because cross‐border sites are both home to and frequented by mobile populations, sampling both resident and non‐resident populations from public places using the PLACE sampling methodology was an important strength of this study. Cross‐border areas are important mixing grounds between resident populations and non‐resident populations travelling through the site or visiting the site for work, commerce or socializing. Such mixing between population subgroups provides important opportunities for HIV transmission 32, 33, 34, 35, 36. Accordingly, “knowing the epidemic” in a cross‐border area involves measuring viral suppression among all people who can be found in the site, and the prevention of HIV transmission must include HIV care and treatment for both resident and non‐resident groups. Furthermore, cross‐border areas are places where behavioural determinants of transmission such as new sexual partnership rates and sexual mixing may be higher than in other areas. Many public places in cross‐border areas (48% of those sampled for verification) offer opportunities for sex on site and, therefore, direct opportunities for HIV transmission 37, 38. Venues with sex on site included not only brothels and hotels, but also bars, restaurants and nightclubs. Using the PLACE method to recruit people socializing at such venues allowed inclusion of groups at highest risk for transmitting HIV infection and those traditionally missed by household surveys, including the cross‐border priority populations of female sex workers, fisher folk and long distance truck drivers 37. Suboptimal services for people living with HIV, coupled with increased mixing and high partnership rates, means that cross‐border areas may be important drivers of the spread of the HIV epidemic across East Africa. This study has several limitations. The non‐resident population described here is likely a heterogeneous group of individuals that included long‐term visitors to the site, daily commuters to the site for work or commerce or residents of neighbouring communities. The specific composition of this group in each cross border area may have an impact on the effectiveness of any intervention aimed at improving viral suppression. Moreover, the concept of “residence” itself is vague and may have implied different definitions to different respondents. In addition, some individuals refused the HIV test. We accounted for informative refusals of the HIV test among those who participated in the survey by up‐weighting those who agreed to be tested to represent all participants who responded to the survey, conditional on covariates. However, these weights did not account for any systematic bias that may have occurred if HIV‐positive individuals who were sampled simply refused to participate in the survey altogether.

Conclusions

Despite these limitations, this study represents the most complete information available on the HIV care and treatment cascade in strategically important cross‐border areas in East Africa. Findings suggest that people with HIV who can be found in cross‐border areas are unlikely to know their status. Moreover, people travelling outside their area of residence may face serious barriers to maintaining viral suppression even after starting treatment. These barriers could include lack of knowledge about where to get ART while away from home, cost of obtaining ART when travelling outside one's country of residence, or suboptimal outcomes due to switching regimens when obtaining ART in different countries 19. Halting the HIV epidemic in East Africa requires preventing transmission of HIV from people infected with HIV to their uninfected partners. Improving viral suppression among populations as they travel away from home may be an efficient means to reduce HIV transmission in cross‐border areas and beyond.

Competing interests

The other authors declare no conflicts of interest.

Authors’ contribution

JKE designed the study, oversaw data collection, performed the analysis and wrote the manuscript. PA, EAB and JTO were involved in designing and conducting the study and revised the manuscript. FS, GM and MM were involved in study design, overseeing data collection, analysis and revision of the manuscript. AV participated in data analysis and revised the manuscript. SS was involved in study design and revised the manuscript. Appendix S1. Sampling details. Click here for additional data file.
  31 in total

1.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

2.  Prevalence of HIV and Associated Risk Factors Among Long Distance Truck Drivers in Inchope, Mozambique, 2012.

Authors:  Carlos Botão; Roberta Z Horth; Heidi Frank; Beverley Cummings; Celso Inguane; Isabel Sathane; Willi McFarland; H Fisher Raymond; Peter W Young
Journal:  AIDS Behav       Date:  2016-04

3.  High Mobility and HIV Prevalence Among Female Market Traders in East Africa in 2014.

Authors:  Carol S Camlin; Alison M El Ayadi; Zachary A Kwena; Willi McFarland; Mallory O Johnson; Torsten B Neilands; Elizabeth A Bukusi; Craig R Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

4.  Spatial phylodynamics of HIV-1 epidemic emergence in east Africa.

Authors:  Rebecca R Gray; Andrew J Tatem; Susanna Lamers; Wei Hou; Oliver Laeyendecker; David Serwadda; Nelson Sewankambo; Ronald H Gray; Maria Wawer; Thomas C Quinn; Maureen M Goodenow; Marco Salemi
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

5.  Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.

Authors:  Maya Petersen; Laura Balzer; Dalsone Kwarsiima; Norton Sang; Gabriel Chamie; James Ayieko; Jane Kabami; Asiphas Owaraganise; Teri Liegler; Florence Mwangwa; Kevin Kadede; Vivek Jain; Albert Plenty; Lillian Brown; Geoff Lavoy; Joshua Schwab; Douglas Black; Mark van der Laan; Elizabeth A Bukusi; Craig R Cohen; Tamara D Clark; Edwin Charlebois; Moses Kamya; Diane Havlir
Journal:  JAMA       Date:  2017-06-06       Impact factor: 56.272

6.  HIV prevalence and risk in long-distance truck drivers in South Africa: a national cross-sectional survey.

Authors:  Sinead Delany-Moretlwe; Braimoh Bello; Peter Kinross; Monique Oliff; Matthew Chersich; Immo Kleinschmidt; Helen Rees
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

7.  Exploring venue-associated risk: a comparison of multiple partnerships and syphilis infection among women working at entertainment and service venues.

Authors:  Sharon S Weir; Jing Li; Jessie K Edwards; Anisha D Gandhi; Yingying Huang; Huang Yingying; Chirayath M Suchindran; Xiang-Sheng Chen
Journal:  AIDS Behav       Date:  2014-02

8.  Cross-border sexual transmission of the newly emerging HIV-1 clade CRF51_01B.

Authors:  Hui Ting Cheong; Kim Tien Ng; Lai Yee Ong; Jack Bee Chook; Kok Gan Chan; Yutaka Takebe; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

9.  Risk Denial and Socio-Economic Factors Related to High HIV Transmission in a Fishing Community in Rakai, Uganda: A Qualitative Study.

Authors:  Muhamadi Lubega; Neema Nakyaanjo; Sumaya Nansubuga; Edgar Hiire; Godfrey Kigozi; Gertrude Nakigozi; Tom Lutalo; Fred Nalugoda; David Serwadda; Ronald Gray; Maria Wawer; Caitylin Kennedy; Steven James Reynolds
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

10.  HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.

Authors:  Richard Hayes; Helen Ayles; Nulda Beyers; Kalpana Sabapathy; Sian Floyd; Kwame Shanaube; Peter Bock; Sam Griffith; Ayana Moore; Deborah Watson-Jones; Christophe Fraser; Sten H Vermund; Sarah Fidler
Journal:  Trials       Date:  2014-02-13       Impact factor: 2.279

View more
  9 in total

Review 1.  Mobility and its Effects on HIV Acquisition and Treatment Engagement: Recent Theoretical and Empirical Advances.

Authors:  Carol S Camlin; Edwin D Charlebois
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

2.  The Intersection of Inequitable Gender Norm Endorsement and HIV Stigma: Implications for HIV Care Engagement for Men in Ugandan Fishing Communities.

Authors:  K M Sileo; R K Wanyenze; B Mukasa; W Musoke; S M Kiene
Journal:  AIDS Behav       Date:  2021-02-10

3.  Access to HIV prevention services in East African cross-border areas: a 2016-2017 cross-sectional bio-behavioural study.

Authors:  Arti V Virkud; Peter Arimi; Freddie Ssengooba; Grace E Mulholland; Michael E Herce; Milissa Markiewicz; Sharon Weir; Jessie K Edwards
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

4.  Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.

Authors:  Martin Plymoth; Eduard J Sanders; Elise M Van Der Elst; Patrik Medstrand; Fregenet Tesfaye; Niclas Winqvist; Taye Balcha; Per Björkman
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240

5.  Community-based progress indicators for prevention of mother-to-child transmission and mortality rates in HIV-exposed children in rural Mozambique.

Authors:  Laura Fuente-Soro; Sheila Fernández-Luis; Elisa López-Varela; Orvalho Augusto; Tacilta Nhampossa; Ariel Nhacolo; Edson Bernardo; Blanca Burgueño; Bernadette Ngeno; Aleny Couto; Helga Guambe; Kwalila Tibana; Marilena Urso; Denise Naniche
Journal:  BMC Public Health       Date:  2021-03-17       Impact factor: 3.295

Review 6.  The HIV care cascade in sub-Saharan Africa: systematic review of published criteria and definitions.

Authors:  Catrina Mugglin; Delia Kläger; Aysel Gueler; Fiona Vanobberghen; Brian Rice; Matthias Egger
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

7.  Prevalence and Predictors of Persistent Human Immunodeficiency Virus Viremia and Viral Rebound After Universal Test and Treat: A Population-Based Study.

Authors:  M Kate Grabowski; Eshan U Patel; Gertrude Nakigozi; Victor Ssempijja; Robert Ssekubugu; Joseph Ssekasanvu; Anthony Ndyanabo; Godfrey Kigozi; Fred Nalugoda; Ronald H Gray; Sarah Kalibbala; David M Serwadda; Oliver Laeyendecker; Maria J Wawer; Larry W Chang; Thomas C Quinn; Joseph Kagaayi; Aaron A R Tobian; Steven J Reynolds
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 7.759

8.  Improving HIV outreach testing yield at cross-border venues in East Africa.

Authors:  Jessie K Edwards; Peter Arimi; Freddie Ssengooba; Michael E Herce; Grace Mulholland; Milissa Markiewicz; Susan Babirye; Steven Ssendagire; Sharon S Weir
Journal:  AIDS       Date:  2020-05-01       Impact factor: 4.632

9.  Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.

Authors:  Tafireyi Marukutira; Richard T Gray; Caitlin Douglass; Carol El-Hayek; Clarissa Moreira; Jason Asselin; Basil Donovan; Tobias Vickers; Tim Spelman; Suzanne Crowe; Rebecca Guy; Mark Stoove; Margaret Hellard
Journal:  PLoS Med       Date:  2020-03-10       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.